Natural Killer Cells Do Not Attenuate a Mouse-Adapted SARS-CoV-2-Induced Disease in
Animals
Killer Cells, Natural
/ immunology
COVID-19
/ immunology
Mice
SARS-CoV-2
/ immunology
Disease Models, Animal
Mice, Inbred C57BL
DNA-Binding Proteins
/ genetics
Mice, Knockout
Humans
Lung
/ pathology
Angiotensin-Converting Enzyme 2
/ genetics
B-Lymphocytes
/ immunology
Female
T-Lymphocytes
/ immunology
B cells
COVID-19
MA30
NK cells
SARS-CoV-2
T cells
Journal
Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722
Informations de publication
Date de publication:
15 Apr 2024
15 Apr 2024
Historique:
received:
25
01
2024
revised:
09
04
2024
accepted:
10
04
2024
medline:
27
4
2024
pubmed:
27
4
2024
entrez:
27
4
2024
Statut:
epublish
Résumé
This study investigates the roles of T, B, and Natural Killer (NK) cells in the pathogenesis of severe COVID-19, utilizing mouse-adapted SARS-CoV-2-MA30 (MA30). To evaluate this MA30 mouse model, we characterized MA30-infected C57BL/6 mice (B6) and compared them with SARS-CoV-2-WA1 (an original SARS-CoV-2 strain) infected K18-human ACE2 (
Identifiants
pubmed: 38675952
pii: v16040611
doi: 10.3390/v16040611
pii:
doi:
Substances chimiques
Rag2 protein, mouse
0
DNA-Binding Proteins
0
Angiotensin-Converting Enzyme 2
EC 3.4.17.23
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIH HHS
ID : NIH 2 P51OD011104-62
Pays : United States
Organisme : NIH HHS
ID : R01DK129881
Pays : United States
Organisme : NIH HHS
ID : R01HL165265
Pays : United States
Organisme : NIH HHS
ID : R35 HL139930
Pays : United States